Lomonggo, Gilberta B.
HRN: 27-08-04 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2025
CEFTRIAXONE 1G (VIAL)
05/03/2025
05/09/2025
IV
2g
OD
Infectious Diarrhea; CVD Infarct
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes